Metabolic response as assessed by 18 F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee-Reference-Cited by-同舟云学术

Metabolic response as assessed by 18 F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

Published:2020-12-19 Issue:3 Volume:10 Page:857-866
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Harrison Douglas J.¹^ORCID,Chi Yueh‐Yun²,Tian Jing²,Hingorani Pooja¹,Mascarenhas Leo³,McCowage Geoffrey B.⁴,Weigel Brenda J.⁵,Venkatramani Rajkumar⁶,Wolden Suzanne L.⁷,Yock Torunn I.⁸,Rodeberg David A.⁹,Hayes‐Jordan Andrea A.¹⁰,Teot Lisa A.¹¹,Spunt Sheri L.¹²^ORCID,Meyer William H.¹³,Hawkins Douglas S.¹⁴,Shulkin Barry L.¹⁵,Parisi Marguerite T.¹⁴

Affiliation:

1. University of Texas MD Anderson Cancer Center Houston TX USA

2. University of Florida Gainesville FL USA

3. Children's Hospital Los Angeles and University of Southern California Keck School of Medicine Los Angeles CA USA

4. The Children's Hospital at Westmead Weastmead NSW Australia

5. University of Minnesota/Masonic Cancer Center Minneapolis MN USA

6. Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston TX USA

7. Memorial Sloan Kettering Cancer Center New York NY USA

8. Massachusetts General Hospital Cancer Center Boston MA USA

9. East Carolina University Greenville NC USA

10. UNC Lineberger Comprehensive Cancer Center Chapel Hill NC USA

11. Boston Children's Hospital Boston MA USA